PIP--Two insider buys at exactly 430,000 shares at $3.50 came through after the close. One is MPM BIOVENTURES III LLC and the other is Evnin Luke. The stock closed at $3.38. Now this one has gotten a lot of play on other boards due to a big run, but why would insiders still be buying? Well, because they know something is normally the right answer. Do your own DD!!
insider data comes from www.scumfish.com
Losing
PharmAthene, Inc. is a biodefense company engaged in the development and commercialization of medical countermeasures against biological and chemical weapons. It has five product candidates in various stages of development: SparVax, recombinant protective antigen (rPA) anthrax vaccine; Valortim, a human monoclonal antibody for the prevention and treatment of anthrax infection; Protexia, a recombinant enzyme (butyrylcholinesterase), which mimics a natural bioscavenger for the prevention or treatment of nerve agent poisoning by organophosphate compounds, including nerve gases and pesticides; a third generation rPA anthrax vaccine, and RypVax, a recombinant dual antigen vaccine for pneumonic and bubonic plague (rYP).
